Better access to tuberculosis testing is a key priority for fighting tuberculosis, the leading cause of infectious disease deaths in people. Despite the roll-out of molecular WHO-recommended rapid diagnostics to replace sputum smear microscopy over the past decade, a large diagnostic gap remains. Of the estimated 10ยท6 million people who developed tuberculosis globally in 2022, more than 3ยท1 million were not diagnosed. An exclusive focus on improving tuberculosis test accuracy alone will not โฆ